Baxter International Inc (BAX) 46.28 $BAX
Global Infusion Pumps Market Growth of 5% CAGR by 2025 - Analysis, Technologies & Forecasts Report 2015-2025 - Key Vendors: Baxter International, Braun Melsungen, Medtronic - Research and Markets
BusinessWire - Thu Sep 01, 5:32AM CDT
Research and Markets has announced the addition of the "Infusion Pumps Market: Global Industry Analysis and Opportunity Assessment, 2015-2025" report to their offering.
MDT: 87.32 (+0.34), BAX: 46.28 (+0.10)
Baxter International Set to Possibly Rebound After Yesterday's Selloff of 1.03%
Comtex SmarTrend(R) - Tue Aug 30, 1:55PM CDT
Baxter International (NYSE:BAX) traded in a range yesterday that spanned from a low of $46.78 to a high of $47.73. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $46.91 on volume of 1.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BAX: 46.28 (+0.10)
Baxter and Satellite Healthcare Partner to Bring Innovative Dialysis Care to More Patients
BusinessWire - Thu Aug 25, 7:30AM CDT
--Agreement features Baxter's industry-leading AMIA APD system with SHARESOURCE, REVACLEAR high-flux dialyzer and CRRT products
BAX: 46.28 (+0.10)
Phibro Animal Health: Currency & Competition Woes Persist
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 3:33PM CDT
Phibro (PAHC) faces competition from generic alternatives of some of its products that may weigh on its future financial health and operational performance.
GWPH: 82.73 (+0.45), PAHC: 25.86 (+0.27), BAX: 46.28 (+0.10), QDEL: 21.58 (-0.16)
Baxter International (BAX) Approaches New Downside Target of $47.40
Comtex SmarTrend(R) - Mon Aug 22, 8:41AM CDT
Shares of Baxter International (NYSE:BAX) have bearishly opened below the pivot of $47.87 today and have reached the first support level of $47.67. Should the shares continue to fall, the support pivots of $47.40 and $46.93 will be of interest.
BAX: 46.28 (+0.10)
SmarTrend Watching for Potential Rebound in Shares of Baxter International After 1.39% Loss
Comtex SmarTrend(R) - Wed Aug 17, 1:05PM CDT
Baxter International (NYSE:BAX) traded in a range yesterday that spanned from a low of $47.55 to a high of $48.35. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $48.05 on volume of 1.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BAX: 46.28 (+0.10)
Luminex (LMNX) Receives FDA Clearance for xMAP Assay
Zacks Equity Research - Zacks Investment Research - Mon Aug 15, 9:24AM CDT
Luminex announced the receipt of Emergency Use Authorization (EUA) from FDA for the xMAP MultiFLEX Zika RNA Assay.
BAX: 46.28 (+0.10), QDEL: 21.58 (-0.16), LMNX: 21.12 (+0.19), NUVA: 66.74 (+0.68)
Akers Biosciences (AKER) Q2 Loss Narrows Y/Y, Stock Gains
Zacks Equity Research - Zacks Investment Research - Fri Aug 12, 8:16AM CDT
Shares of Akers Biosciences increased almost 3% to close at $3.17 on Aug 11, after the company reported second-quarter 2016 results.
BAX: 46.28 (+0.10), QDEL: 21.58 (-0.16), AKER: 3.66 (+0.13), NUVA: 66.74 (+0.68)
Baxter International Set to Possibly Pullback After Yesterday's Rally of 1.26%
Comtex SmarTrend(R) - Thu Aug 11, 12:49PM CDT
Baxter International (NYSE:BAX) traded in a range yesterday that spanned from a low of $48.60 to a high of $49.31. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $48.70 on volume of 1.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BAX: 46.28 (+0.10)
Watch for Shares of Baxter International (BAX) to Approach Resistance at $49.11
Comtex SmarTrend(R) - Thu Aug 11, 9:24AM CDT
Baxter International (NYSE:BAX) has opened bullishly above the pivot of $48.44 today and has reached the first level of resistance at $48.85. Investors may be interested in a cross of the next upside pivot targets of $49.11 and $49.77.
BAX: 46.28 (+0.10)
Alere (ALR) Reader Attains CE Mark, Submits Delayed 10K
Zacks Equity Research - Zacks Investment Research - Thu Aug 11, 7:08AM CDT
Alere Inc. (ALR) recently announced the receipt of In-Vitro Diagnostic (IVD) CE marking for its new Alere Reader.
BAX: 46.28 (+0.10), QDEL: 21.58 (-0.16), ALR: 39.13 (+0.69), NUVA: 66.74 (+0.68)
Baxter's Sigma Spectrum Infusion System Rates Highest in Drug Library Compliance and Ease-of-Use According to KLAS Report
BusinessWire - Thu Aug 11, 7:00AM CDT
--Report Highlights ''Simple, Strong Design'' of Sigma Spectrum User Interface
BAX: 46.28 (+0.10)
Fitch Rates Baxter International Inc.'s Notes Offering 'BBB+'
BusinessWire - Wed Aug 10, 8:13AM CDT
Fitch Ratings has assigned a 'BBB+' rating to Baxter International Inc.'s (Baxter) senior unsecured notes offering. Fitch expects the net proceeds from the issuance to be used to pay down existing debt and short-term borrowings, as well as other general corporate purposes.
BAX: 46.28 (+0.10)
Baxter International (BAX): Strong Industry, Solid Earnings Estimate Revisions
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 8:40AM CDT
Baxter International (BAX) is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective
BAX: 46.28 (+0.10)
Sunshine Heart Announces Strategic Acquisition of Aquadex Product Line from Baxter and a new credit facility with Silicon Valley Bank
Globe Newswire - Mon Aug 08, 4:30AM CDT
EDEN PRAIRIE, Minn., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced it has acquired the Aquadex product line from an indirect subsidiary of Baxter International Inc. (NYSE:BAX), a global leader in the hospital products and dialysis markets. The Aquadex system is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.
SSH: 0.83 (unch), BAX: 46.28 (+0.10)
Zacks.com featured highlights: Tallgrass Energy GP, Baxter International, AO Smith, Southwestern Energy and Rollins
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 8:30AM CDT
Zacks.com featured highlights: Tallgrass Energy GP, Baxter International, AO Smith, Southwestern Energy and Rollins
BAX: 46.28 (+0.10), ROL: 29.09 (+0.29), SWN: 13.93 (+0.14), AOS: 96.98 (+0.62), TEGP: 23.26 (-0.11)
After Yesterday's Rally of 1.47% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Aug 01, 2:01PM CDT
Baxter International (NYSE:BAX) traded in a range yesterday that spanned from a low of $47.99 to a high of $48.73. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $48.50 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BAX: 46.28 (+0.10)
Buy These 5 Efficient Stocks for Big Upside Potential
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 7:41AM CDT
A portfolio that has been built up by investing in efficient companies may prove to be profitable irrespective of market conditions.
BAX: 46.28 (+0.10), ROL: 29.09 (+0.29), SWN: 13.93 (+0.14), TEGP: 23.26 (-0.11), AOS: 96.98 (+0.62)
Boston Scientific (BSX) Meets Q2 Earnings Estimate, Views Up
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 2:03PM CDT
Boston Scientific Corporation (BSX) announced adjusted EPS of 27 cents in the second quarter of 2016, up 22.7% from the year-ago quarter.
BSX: 24.26 (-0.07), GWPH: 82.73 (+0.45), BAX: 46.28 (+0.10), VASC: 48.99 (+0.53)
Global Infusion Pumps Market Growth of 5% CAGR by 2025 - Analysis, Technologies & Forecasts Report 2015-2025 - Key Vendors: Baxter International, Braun Melsungen, Medtronic - Research and Markets
BusinessWire - Thu Sep 01, 5:32AM CDT
Research and Markets has announced the addition of the "Infusion Pumps Market: Global Industry Analysis and Opportunity Assessment, 2015-2025" report to their offering.
MDT: 87.32 (+0.34), BAX: 46.28 (+0.10)
Baxter International Set to Possibly Rebound After Yesterday's Selloff of 1.03%
Comtex SmarTrend(R) - Tue Aug 30, 1:55PM CDT
Baxter International (NYSE:BAX) traded in a range yesterday that spanned from a low of $46.78 to a high of $47.73. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $46.91 on volume of 1.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BAX: 46.28 (+0.10)
Baxter and Satellite Healthcare Partner to Bring Innovative Dialysis Care to More Patients
BusinessWire - Thu Aug 25, 7:30AM CDT
--Agreement features Baxter's industry-leading AMIA APD system with SHARESOURCE, REVACLEAR high-flux dialyzer and CRRT products
BAX: 46.28 (+0.10)
Phibro Animal Health: Currency & Competition Woes Persist
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 3:33PM CDT
Phibro (PAHC) faces competition from generic alternatives of some of its products that may weigh on its future financial health and operational performance.
GWPH: 82.73 (+0.45), PAHC: 25.86 (+0.27), BAX: 46.28 (+0.10), QDEL: 21.58 (-0.16)
Baxter International (BAX) Approaches New Downside Target of $47.40
Comtex SmarTrend(R) - Mon Aug 22, 8:41AM CDT
Shares of Baxter International (NYSE:BAX) have bearishly opened below the pivot of $47.87 today and have reached the first support level of $47.67. Should the shares continue to fall, the support pivots of $47.40 and $46.93 will be of interest.
BAX: 46.28 (+0.10)
SmarTrend Watching for Potential Rebound in Shares of Baxter International After 1.39% Loss
Comtex SmarTrend(R) - Wed Aug 17, 1:05PM CDT
Baxter International (NYSE:BAX) traded in a range yesterday that spanned from a low of $47.55 to a high of $48.35. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $48.05 on volume of 1.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BAX: 46.28 (+0.10)
Luminex (LMNX) Receives FDA Clearance for xMAP Assay
Zacks Equity Research - Zacks Investment Research - Mon Aug 15, 9:24AM CDT
Luminex announced the receipt of Emergency Use Authorization (EUA) from FDA for the xMAP MultiFLEX Zika RNA Assay.
BAX: 46.28 (+0.10), QDEL: 21.58 (-0.16), LMNX: 21.12 (+0.19), NUVA: 66.74 (+0.68)
Akers Biosciences (AKER) Q2 Loss Narrows Y/Y, Stock Gains
Zacks Equity Research - Zacks Investment Research - Fri Aug 12, 8:16AM CDT
Shares of Akers Biosciences increased almost 3% to close at $3.17 on Aug 11, after the company reported second-quarter 2016 results.
BAX: 46.28 (+0.10), QDEL: 21.58 (-0.16), AKER: 3.66 (+0.13), NUVA: 66.74 (+0.68)
Baxter International Set to Possibly Pullback After Yesterday's Rally of 1.26%
Comtex SmarTrend(R) - Thu Aug 11, 12:49PM CDT
Baxter International (NYSE:BAX) traded in a range yesterday that spanned from a low of $48.60 to a high of $49.31. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $48.70 on volume of 1.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BAX: 46.28 (+0.10)
Watch for Shares of Baxter International (BAX) to Approach Resistance at $49.11
Comtex SmarTrend(R) - Thu Aug 11, 9:24AM CDT
Baxter International (NYSE:BAX) has opened bullishly above the pivot of $48.44 today and has reached the first level of resistance at $48.85. Investors may be interested in a cross of the next upside pivot targets of $49.11 and $49.77.
BAX: 46.28 (+0.10)
Alere (ALR) Reader Attains CE Mark, Submits Delayed 10K
Zacks Equity Research - Zacks Investment Research - Thu Aug 11, 7:08AM CDT
Alere Inc. (ALR) recently announced the receipt of In-Vitro Diagnostic (IVD) CE marking for its new Alere Reader.
BAX: 46.28 (+0.10), QDEL: 21.58 (-0.16), ALR: 39.13 (+0.69), NUVA: 66.74 (+0.68)
Baxter's Sigma Spectrum Infusion System Rates Highest in Drug Library Compliance and Ease-of-Use According to KLAS Report
BusinessWire - Thu Aug 11, 7:00AM CDT
--Report Highlights ''Simple, Strong Design'' of Sigma Spectrum User Interface
BAX: 46.28 (+0.10)
Fitch Rates Baxter International Inc.'s Notes Offering 'BBB+'
BusinessWire - Wed Aug 10, 8:13AM CDT
Fitch Ratings has assigned a 'BBB+' rating to Baxter International Inc.'s (Baxter) senior unsecured notes offering. Fitch expects the net proceeds from the issuance to be used to pay down existing debt and short-term borrowings, as well as other general corporate purposes.
BAX: 46.28 (+0.10)
Baxter International (BAX): Strong Industry, Solid Earnings Estimate Revisions
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 8:40AM CDT
Baxter International (BAX) is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective
BAX: 46.28 (+0.10)
Sunshine Heart Announces Strategic Acquisition of Aquadex Product Line from Baxter and a new credit facility with Silicon Valley Bank
Globe Newswire - Mon Aug 08, 4:30AM CDT
EDEN PRAIRIE, Minn., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced it has acquired the Aquadex product line from an indirect subsidiary of Baxter International Inc. (NYSE:BAX), a global leader in the hospital products and dialysis markets. The Aquadex system is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.
SSH: 0.83 (unch), BAX: 46.28 (+0.10)
Zacks.com featured highlights: Tallgrass Energy GP, Baxter International, AO Smith, Southwestern Energy and Rollins
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 8:30AM CDT
Zacks.com featured highlights: Tallgrass Energy GP, Baxter International, AO Smith, Southwestern Energy and Rollins
BAX: 46.28 (+0.10), ROL: 29.09 (+0.29), SWN: 13.93 (+0.14), AOS: 96.98 (+0.62), TEGP: 23.26 (-0.11)
After Yesterday's Rally of 1.47% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Aug 01, 2:01PM CDT
Baxter International (NYSE:BAX) traded in a range yesterday that spanned from a low of $47.99 to a high of $48.73. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $48.50 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BAX: 46.28 (+0.10)
Buy These 5 Efficient Stocks for Big Upside Potential
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 7:41AM CDT
A portfolio that has been built up by investing in efficient companies may prove to be profitable irrespective of market conditions.
BAX: 46.28 (+0.10), ROL: 29.09 (+0.29), SWN: 13.93 (+0.14), TEGP: 23.26 (-0.11), AOS: 96.98 (+0.62)
Boston Scientific (BSX) Meets Q2 Earnings Estimate, Views Up
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 2:03PM CDT
Boston Scientific Corporation (BSX) announced adjusted EPS of 27 cents in the second quarter of 2016, up 22.7% from the year-ago quarter.
BSX: 24.26 (-0.07), GWPH: 82.73 (+0.45), BAX: 46.28 (+0.10), VASC: 48.99 (+0.53)
